Lung transplantation: opportunities for research and clinical advancement.
about
Diagnostic value of plasma and bronchoalveolar lavage samples in acute lung allograft rejection: differential cytologyLung donor selection criteriaChemokines as mediators of neovascularizationDe novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection.The 4G/4G genotype of the PAI-1 (serpine-1) 4G/5G polymorphism is associated with decreased lung allograft utilizationProtection against bronchiolitis obliterans syndrome is associated with allograft CCR7+ CD45RA- T regulatory cellsPlatelet activation in the postoperative period after lung transplantation.Targeted endothelial delivery of nanosized catalase immunoconjugates protects lung grafts donated after cardiac death.The endogenous pro-resolving mediators lipoxin A4 and resolvin E1 preserve organ function in allograft rejection.ICOS-expressing lymphocytes promote resolution of CD8-mediated lung injury in a mouse model of lung rejectionResident tissue-specific mesenchymal progenitor cells contribute to fibrogenesis in human lung allograftsUpdate in transplantation 2005.Human and murine obliterative bronchiolitis in transplantNovel insights into lung transplant rejection by microarray analysisImmunoglobulin G levels before and after lung transplantation.CD154 deficiency uncouples allograft CD8+ T-cell effector function from proliferation and inhibits murine airway obliterationAntioxidant enzyme gene transfer for ischemic diseases.Gene set enrichment analysis identifies key innate immune pathways in primary graft dysfunction after lung transplantation.CASE 7--2014 Rescue therapy with early extracorporeal membrane oxygenation for primary graft dysfunction after bilateral lung transplantation.A review of the potential applications and controversies of non-invasive testing for biomarkers of aspiration in the lung transplant populationRole of bacterial infections in allograft rejection.Bronchoalveolar lavage and other methods to define the human respiratory tract milieu in health and disease.Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator.Giving new life to old lungs: methods to produce and assess whole human paediatric bioengineered lungs.Inhibition of β-catenin/p300 interaction proximalizes mouse embryonic lung epithelium.Pulmonary hypertension in patients with bronchiolitis obliterans syndrome listed for retransplantation.CD154 blockade abrogates allospecific responses and enhances CD4(+) regulatory T-cells in mouse orthotopic lung transplant.Epithelial-mesenchymal transition: potential role in obliterative bronchiolitis?The diagnostic value of gastroesophageal reflux disease (GERD) symptoms and detection of pepsin and bile acids in bronchoalveolar lavage fluid and exhaled breath condensate for identifying lung transplantation patients with GERD-induced aspiration.Human immunology studies using organ donors: Impact of clinical variations on immune parameters in tissues and circulation.
P2860
Q26744274-F0EFE252-CDB7-4F3B-83B8-FE0C9203AAC4Q26999347-F3CF18F9-2FC0-4340-AF91-2EEECDA60265Q30438032-410EF52D-B78C-46FC-85A9-781911509B3AQ33551885-D6F973F5-7EA2-4C58-B67E-5032806DD872Q33599073-321CB875-C377-498A-880E-D2C82DC4F805Q33627550-27D96BB6-E929-4488-AA89-6868FA6C9E03Q33691702-6C051FE1-D83B-41FF-B2FB-6B4E489351DDQ33893438-551FFCEF-8C33-4852-BCDB-AD657C859702Q34482353-D09F3862-93B0-4DE3-BFAD-719BDD4DB981Q34965591-AD469526-2A04-4A47-BE2D-F64FC56D89A2Q35070897-B36E0BA6-5654-4787-AA9B-43DCB1669D02Q36416045-187BE3E1-2E75-4D7E-93E5-CBF403F619ABQ36698807-EDDEAEC2-00F6-4E39-9566-63CCF18EDD0EQ36698811-1DABD742-2DA3-4F14-8BC3-4463A32C6A05Q37144299-9AEC712E-16AA-4005-8AF2-74CD3BA1C9DDQ37308134-11D13ECB-839C-4672-BDDE-6150B5DA0D60Q37398189-80701C3F-6C75-4470-9CEE-C55A1252C10FQ37638592-0CB727BC-7D33-40BD-A588-2F491CF910C7Q37671669-C3EBD8B9-8540-4CAF-B358-C75E02B54A4DQ37717775-CCA01EBA-0AB2-4201-9853-9D13405C431DQ37754716-96EDF475-B286-43B7-8EDA-C24B95D8B40EQ37847083-7183CAF1-39F0-43EA-9DA4-E695E764F82DQ40418033-61B8B200-B4D0-45A9-B983-57BFAE8A7CDFQ40836575-7CA64620-CDB5-4A38-8186-8BDB56805366Q42151507-FC58231E-881A-4904-AC7E-E5B0F17D2A32Q42657222-31658A48-E56E-462F-943A-31A5381BC885Q42907214-39929E2D-A092-4695-9CBA-98E03246D62BQ42911024-DA2C4584-A878-462D-AF45-A679B4488BC5Q46618370-E8AD1385-E183-4048-9115-FCAB6D211F82Q48108184-C3801DE9-0DD3-4705-B747-9C09C29C2404
P2860
Lung transplantation: opportunities for research and clinical advancement.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Lung transplantation: opportunities for research and clinical advancement.
@ast
Lung transplantation: opportunities for research and clinical advancement.
@en
type
label
Lung transplantation: opportunities for research and clinical advancement.
@ast
Lung transplantation: opportunities for research and clinical advancement.
@en
prefLabel
Lung transplantation: opportunities for research and clinical advancement.
@ast
Lung transplantation: opportunities for research and clinical advancement.
@en
P2093
P2860
P1476
Lung transplantation: opportunities for research and clinical advancement.
@en
P2093
David S Wilkes
Herbert Y Reynolds
Thomas M Egan
P2860
P304
P356
10.1164/RCCM.200501-098WS
P407
P577
2005-07-14T00:00:00Z